Immunohistochemical staining for desmogleins I and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin
1998

Desmoglein Staining in Skin Tumors

Sample size: 66 publication Evidence: moderate

Author Information

Author(s): AL Krunic, DR Garrod, S Madani, MD Buchanan, RE Clark

Primary Institution: Duke University Medical Center

Hypothesis

How does desmosomal staining correlate with the clinical, biological, and histopathological features of keratinocytic neoplasms?

Conclusion

Immunohistochemical analysis shows distinct staining patterns for desmoglein in keratoacanthoma compared to squamous cell carcinoma and actinic keratosis.

Supporting Evidence

  • All keratoacanthomas showed extensive pericellular staining for desmoglein.
  • Squamous cell carcinomas demonstrated significant reduction in desmoglein staining.
  • Actinic keratosis showed focal loss of desmoglein marker in dysplastic areas.

Takeaway

This study looked at how a specific protein in skin tumors can help tell the difference between different types of skin growths.

Methodology

The study involved immunohistochemical staining of biopsy samples from patients with actinic keratosis, keratoacanthoma, and squamous cell carcinoma.

Limitations

The study excluded certain types of squamous cell carcinomas and focused only on specific biopsy samples.

Participant Demographics

The study included 36 patients with skin tumors from predominantly sun-exposed sites.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication